Trial Profile
Multi-centre, International Study of Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Eviplera) in Routine Clinical Settings.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 01 Mar 2016 New trial record